Medexus Pharmaceuticals (PDDPF) Stock Price, News & Analysis

Company Overview

Medexus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on acquiring, commercializing and distributing prescription medicines and other healthcare products in North America. The company emphasizes products that address underserved patient populations and therapeutic areas requiring specialized expertise.

Its portfolio has included Rasuvo, a subcutaneous methotrexate treatment used for conditions such as rheumatoid arthritis, juvenile idiopathic arthritis and psoriasis, as well as IXINITY, a recombinant factor IX product for the treatment and prevention of bleeding in people with hemophilia B. Medexus has also marketed FeraMAX, an oral iron supplement, in Canada.

Medexus serves healthcare providers and patients primarily in Canada and the United States. Its business model centers on licensing, acquiring and expanding the availability of established pharmaceutical products rather than developing a broad pipeline of novel medicines from early-stage research.

Key Stats

• Today's Range: $2.11 to $2.42
• 50-Day Range: $2.14 to $2.14
• 52-Week Range: $1.70 to $3.99
• Volume: 39,966 shs
• Average Volume: 4,355 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:PDDPF
• CIK: N/A
• Web: www.medexus.com
• Phone: (514) 762-2626
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A